"
Gene Expression Profiles Predict Sensitivity of Prostate Cancer to Radiotherapy"
written by Lilach Agemy, Itai Kela, Tova Waks, Raphael M. Pfeffer, Anat Bar-Shira, Avi Orr-Urtreger, Eytan Domany, Zelig Eshhar,
published by
Journal of Cancer Therapy,
Vol.4 No.4A, 2013
has been cited by the following article(s):
[1]
|
The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer
Cancers,
2022
DOI:10.3390/cancers14174095
|
|
|
[2]
|
Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells
Scientific Reports,
2019
DOI:10.1038/s41598-019-44991-w
|
|
|
[3]
|
Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells
Scientific Reports,
2019
DOI:10.1038/s41598-019-44991-w
|
|
|
[4]
|
Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells
Scientific Reports,
2019
DOI:10.1038/s41598-019-44991-w
|
|
|
[5]
|
Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer
Non-Coding RNA,
2018
DOI:10.3390/ncrna4040039
|
|
|